

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.80234224 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.80234224 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.57877268 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.47369112 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.47369112 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 7.42099949 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 7.00746018 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.31820310 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.31046136 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.31046136 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.31046136 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.12443659 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.94692109 |
| 14 | urea cycle (GO:0000050) | 5.94542619 |
| 15 | urea metabolic process (GO:0019627) | 5.94542619 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.92412949 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.72643880 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56075283 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.54806708 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48195150 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 5.46737026 |
| 22 | protein carboxylation (GO:0018214) | 5.37646976 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37646976 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.37291013 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.36408756 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.33990893 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.32850281 |
| 28 | cysteine metabolic process (GO:0006534) | 5.31692458 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 5.08942252 |
| 30 | bile acid metabolic process (GO:0008206) | 5.06242088 |
| 31 | oxidative demethylation (GO:0070989) | 5.02530136 |
| 32 | drug metabolic process (GO:0017144) | 5.01584700 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.98394280 |
| 34 | regulation of complement activation (GO:0030449) | 4.96954163 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.94800127 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.90696289 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.88318748 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82003999 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.81623538 |
| 40 | * serine family amino acid catabolic process (GO:0009071) | 4.78151119 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.75143928 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.75143928 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.75143928 |
| 44 | * alpha-amino acid catabolic process (GO:1901606) | 4.68714055 |
| 45 | lysine metabolic process (GO:0006553) | 4.64408343 |
| 46 | lysine catabolic process (GO:0006554) | 4.64408343 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.62741487 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.62741487 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.62088780 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.59409257 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.59409257 |
| 52 | phospholipid efflux (GO:0033700) | 4.59084058 |
| 53 | coenzyme catabolic process (GO:0009109) | 4.50594892 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.45604898 |
| 55 | regulation of plasminogen activation (GO:0010755) | 4.45580775 |
| 56 | imidazole-containing compound metabolic process (GO:0052803) | 4.44962409 |
| 57 | glycine metabolic process (GO:0006544) | 4.37530000 |
| 58 | cellular biogenic amine catabolic process (GO:0042402) | 4.37507306 |
| 59 | amine catabolic process (GO:0009310) | 4.37507306 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.34316209 |
| 61 | glutamate metabolic process (GO:0006536) | 4.31975491 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.31217356 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.31199882 |
| 64 | * cellular amino acid catabolic process (GO:0009063) | 4.30060498 |
| 65 | phenylpropanoid metabolic process (GO:0009698) | 4.27116711 |
| 66 | negative regulation of blood coagulation (GO:0030195) | 4.23002277 |
| 67 | negative regulation of hemostasis (GO:1900047) | 4.23002277 |
| 68 | cellular glucuronidation (GO:0052695) | 4.22888004 |
| 69 | arginine metabolic process (GO:0006525) | 4.22463278 |
| 70 | cholesterol efflux (GO:0033344) | 4.21258996 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 4.18584619 |
| 72 | opsonization (GO:0008228) | 4.14076150 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.11461124 |
| 74 | ethanol metabolic process (GO:0006067) | 4.10376816 |
| 75 | alkaloid metabolic process (GO:0009820) | 4.07807680 |
| 76 | S-adenosylmethionine metabolic process (GO:0046500) | 4.07363589 |
| 77 | regulation of humoral immune response (GO:0002920) | 4.07361026 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06814881 |
| 79 | drug catabolic process (GO:0042737) | 4.02243702 |
| 80 | serine family amino acid biosynthetic process (GO:0009070) | 4.01137766 |
| 81 | aldehyde catabolic process (GO:0046185) | 4.00039426 |
| 82 | fibrinolysis (GO:0042730) | 3.98618658 |
| 83 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.97579458 |
| 84 | * serine family amino acid metabolic process (GO:0009069) | 3.97506250 |
| 85 | ethanol oxidation (GO:0006069) | 3.96949783 |
| 86 | positive regulation of hemostasis (GO:1900048) | 3.95992133 |
| 87 | positive regulation of blood coagulation (GO:0030194) | 3.95992133 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 3.95714535 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90432415 |
| 90 | negative regulation of coagulation (GO:0050819) | 3.87915409 |
| 91 | cofactor catabolic process (GO:0051187) | 3.85781021 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.85093909 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.80550248 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.79035251 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78071610 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78071610 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77717079 |
| 98 | ketone body metabolic process (GO:1902224) | 3.75801996 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.74941376 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.74941376 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.74678067 |
| 102 | complement activation (GO:0006956) | 3.73911437 |
| 103 | * organic acid catabolic process (GO:0016054) | 3.73412503 |
| 104 | * carboxylic acid catabolic process (GO:0046395) | 3.73412503 |
| 105 | negative regulation of wound healing (GO:0061045) | 3.73128433 |
| 106 | positive regulation of coagulation (GO:0050820) | 3.72715750 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72389877 |
| 108 | negative regulation of protein activation cascade (GO:2000258) | 3.72147492 |
| 109 | protein activation cascade (GO:0072376) | 3.71477740 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.71109535 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.70608540 |
| 112 | cytolysis (GO:0019835) | 3.68373742 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.66040069 |
| 114 | NAD biosynthetic process (GO:0009435) | 3.65301750 |
| 115 | sterol homeostasis (GO:0055092) | 3.64897763 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.62649857 |
| 117 | short-chain fatty acid metabolic process (GO:0046459) | 3.60789693 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.59516504 |
| 119 | acute-phase response (GO:0006953) | 3.59481715 |
| 120 | exogenous drug catabolic process (GO:0042738) | 3.58988167 |
| 121 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.58669484 |
| 122 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.54517157 |
| 123 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.54517157 |
| 124 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.41726155 |
| 125 | acute inflammatory response (GO:0002526) | 3.40088278 |
| 126 | regulation of lipoprotein particle clearance (GO:0010984) | 3.35708185 |
| 127 | protein-lipid complex subunit organization (GO:0071825) | 3.31651039 |
| 128 | heme transport (GO:0015886) | 3.30294614 |
| 129 | regulation of apoptotic cell clearance (GO:2000425) | 3.29586864 |
| 130 | flavonoid metabolic process (GO:0009812) | 3.23497017 |
| 131 | regulation of acute inflammatory response (GO:0002673) | 3.18915342 |
| 132 | negative regulation of complement activation (GO:0045916) | 3.17615154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40880614 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.17949339 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.99937942 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48254225 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.41923753 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.15126610 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.87459536 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06729209 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04067435 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65333166 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08714601 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06883105 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9921858 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99303947 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99089778 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94096764 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77707999 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58536975 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56517726 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53121483 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48805443 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42811704 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42030829 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39278544 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38542178 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30398603 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28647452 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21024427 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19332320 |
| 30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18665281 |
| 31 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17918132 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14624040 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12217183 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06524553 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03125215 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01995661 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99058825 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98086475 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96598002 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94314315 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92819803 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89789168 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89429732 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87224702 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87095552 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85270478 |
| 47 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84781966 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84126151 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82417946 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81625980 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80451034 |
| 52 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80245231 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79893011 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79569646 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79409098 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78807751 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77422093 |
| 58 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77367763 |
| 59 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.77134912 |
| 60 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76756224 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76552289 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76267680 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75580821 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75543359 |
| 65 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74302182 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74064451 |
| 67 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72991863 |
| 68 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72754629 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72225721 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 0.71433068 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70638581 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.70498402 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.70475697 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70259039 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70223256 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 0.70116503 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70077461 |
| 78 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.69128674 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.68911383 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68118402 |
| 81 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.67369180 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66537915 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.65974882 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65655416 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64806162 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64594379 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64149770 |
| 88 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.64100798 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.63758776 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.63637041 |
| 91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.63624904 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62826304 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62779787 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62728917 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62728917 |
| 96 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62680652 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.62226409 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.62124754 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61492242 |
| 100 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.61272186 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.61133488 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61068172 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.60810011 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59132859 |
| 105 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.58404507 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.58246751 |
| 107 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57647018 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57183362 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55869852 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53642752 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53324596 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51777196 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51671455 |
| 114 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.51080644 |
| 115 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50080930 |
| 116 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49474841 |
| 117 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.48954848 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48366634 |
| 119 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47867523 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46358869 |
| 121 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44647662 |
| 122 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44635124 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44565421 |
| 124 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44038401 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43627297 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42866984 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41969960 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41691362 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41494332 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40452685 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40218456 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39774104 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39394236 |
| 134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38869081 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38567385 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38252282 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37754913 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37614209 |
| 139 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37552328 |
| 140 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37222686 |
| 141 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37021083 |
| 142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.35577802 |
| 143 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35509715 |
| 144 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35031845 |
| 145 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.34758803 |
| 146 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34399706 |
| 147 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34103765 |
| 148 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34096123 |
| 149 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33976637 |
| 150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.32938852 |
| 151 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.32887477 |
| 152 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.32835253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25970246 |
| 2 | MP0005360_urolithiasis | 7.59233592 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.47660143 |
| 4 | MP0005365_abnormal_bile_salt | 6.17179992 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.20514130 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.22076294 |
| 7 | MP0003252_abnormal_bile_duct | 3.89967841 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.56476047 |
| 9 | MP0009840_abnormal_foam_cell | 3.36878067 |
| 10 | MP0005083_abnormal_biliary_tract | 2.94872717 |
| 11 | MP0003195_calcinosis | 2.86514639 |
| 12 | MP0005332_abnormal_amino_acid | 2.84388792 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.59816336 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.58567014 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.37961146 |
| 16 | MP0000609_abnormal_liver_physiology | 2.15580073 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.10911428 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.10131647 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.99405872 |
| 20 | MP0003868_abnormal_feces_composition | 1.93611021 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.83574306 |
| 22 | MP0001764_abnormal_homeostasis | 1.70726958 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.62028694 |
| 24 | MP0003303_peritoneal_inflammation | 1.61926528 |
| 25 | MP0009697_abnormal_copulation | 1.58850906 |
| 26 | MP0009785_altered_susceptibility_to | 1.57485105 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56992028 |
| 28 | MP0005451_abnormal_body_composition | 1.48574765 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.36232038 |
| 30 | MP0003011_delayed_dark_adaptation | 1.34799764 |
| 31 | MP0003186_abnormal_redox_activity | 1.27122250 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.25032348 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.23633162 |
| 34 | MP0002419_abnormal_innate_immunity | 1.19424253 |
| 35 | MP0000598_abnormal_liver_morphology | 1.17968410 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.17270332 |
| 37 | MP0005647_abnormal_sex_gland | 1.13399550 |
| 38 | MP0004510_myositis | 1.09219989 |
| 39 | MP0000604_amyloidosis | 1.08099528 |
| 40 | MP0009764_decreased_sensitivity_to | 1.06561528 |
| 41 | MP0002254_reproductive_system_inflammat | 1.03256534 |
| 42 | MP0000343_altered_response_to | 1.02689795 |
| 43 | MP0009763_increased_sensitivity_to | 1.02263597 |
| 44 | MP0005025_abnormal_response_to | 1.00759350 |
| 45 | MP0005670_abnormal_white_adipose | 0.99716075 |
| 46 | MP0003879_abnormal_hair_cell | 0.99087183 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 0.95465306 |
| 48 | MP0010368_abnormal_lymphatic_system | 0.92807071 |
| 49 | MP0001790_abnormal_immune_system | 0.90547477 |
| 50 | MP0005387_immune_system_phenotype | 0.90547477 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 0.90212688 |
| 52 | MP0001835_abnormal_antigen_presentation | 0.89320276 |
| 53 | MP0008469_abnormal_protein_level | 0.89165628 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.87053466 |
| 55 | MP0000685_abnormal_immune_system | 0.83608186 |
| 56 | MP0005408_hypopigmentation | 0.83097671 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.82051162 |
| 58 | MP0005000_abnormal_immune_tolerance | 0.81369894 |
| 59 | MP0005376_homeostasis/metabolism_phenot | 0.81042856 |
| 60 | MP0009765_abnormal_xenobiotic_induced | 0.78417910 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.78229294 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.76677612 |
| 63 | MP0005671_abnormal_response_to | 0.74137326 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 0.74043617 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.74043617 |
| 66 | MP0002971_abnormal_brown_adipose | 0.73802970 |
| 67 | MP0001533_abnormal_skeleton_physiology | 0.71698403 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 0.71203577 |
| 69 | MP0005220_abnormal_exocrine_pancreas | 0.70393734 |
| 70 | MP0003690_abnormal_glial_cell | 0.70034838 |
| 71 | MP0004130_abnormal_muscle_cell | 0.69331798 |
| 72 | MP0005334_abnormal_fat_pad | 0.69229821 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.68991845 |
| 74 | MP0005535_abnormal_body_temperature | 0.66472330 |
| 75 | MP0005266_abnormal_metabolism | 0.66451993 |
| 76 | MP0003329_amyloid_beta_deposits | 0.65853733 |
| 77 | MP0009053_abnormal_anal_canal | 0.64352748 |
| 78 | MP0000920_abnormal_myelination | 0.63243279 |
| 79 | MP0001661_extended_life_span | 0.62779464 |
| 80 | MP0002723_abnormal_immune_serum | 0.62745241 |
| 81 | MP0001800_abnormal_humoral_immune | 0.61752815 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.61177697 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.60289215 |
| 84 | MP0002452_abnormal_antigen_presenting | 0.59792052 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.59716443 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.59099166 |
| 87 | MP0001756_abnormal_urination | 0.58415985 |
| 88 | MP0001915_intracranial_hemorrhage | 0.55669777 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 0.55553584 |
| 90 | MP0005448_abnormal_energy_balance | 0.53608953 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.52396542 |
| 92 | MP0002822_catalepsy | 0.50156836 |
| 93 | MP0005395_other_phenotype | 0.48413357 |
| 94 | MP0008874_decreased_physiological_sensi | 0.48136083 |
| 95 | MP0003633_abnormal_nervous_system | 0.47709129 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.47289555 |
| 97 | MP0002405_respiratory_system_inflammati | 0.46821776 |
| 98 | MP0003718_maternal_effect | 0.46215819 |
| 99 | MP0008873_increased_physiological_sensi | 0.45877481 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.44517854 |
| 101 | MP0003436_decreased_susceptibility_to | 0.42680097 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.42509923 |
| 103 | MP0002928_abnormal_bile_duct | 0.42405618 |
| 104 | MP0003075_altered_response_to | 0.41584024 |
| 105 | MP0002837_dystrophic_cardiac_calcinosis | 0.41487099 |
| 106 | MP0003724_increased_susceptibility_to | 0.41252286 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.41085286 |
| 108 | MP0008872_abnormal_physiological_respon | 0.39331578 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.39312646 |
| 110 | MP0003953_abnormal_hormone_level | 0.39246353 |
| 111 | MP0005166_decreased_susceptibility_to | 0.39156682 |
| 112 | MP0000579_abnormal_nail_morphology | 0.37181286 |
| 113 | MP0009672_abnormal_birth_weight | 0.35525524 |
| 114 | MP0004381_abnormal_hair_follicle | 0.34816957 |
| 115 | MP0009115_abnormal_fat_cell | 0.33464751 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.32400367 |
| 117 | MP0001243_abnormal_dermal_layer | 0.31763485 |
| 118 | MP0002970_abnormal_white_adipose | 0.31657204 |
| 119 | MP0000249_abnormal_blood_vessel | 0.31490322 |
| 120 | MP0000230_abnormal_systemic_arterial | 0.31054650 |
| 121 | MP0002168_other_aberrant_phenotype | 0.30604949 |
| 122 | MP0001853_heart_inflammation | 0.30565634 |
| 123 | MP0004883_abnormal_blood_vessel | 0.30271067 |
| 124 | MP0002796_impaired_skin_barrier | 0.30251791 |
| 125 | MP0001881_abnormal_mammary_gland | 0.28874878 |
| 126 | MP0006082_CNS_inflammation | 0.28669817 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.27629134 |
| 128 | MP0002090_abnormal_vision | 0.26432256 |
| 129 | MP0002060_abnormal_skin_morphology | 0.24963974 |
| 130 | MP0005164_abnormal_response_to | 0.23847383 |
| 131 | MP0002132_abnormal_respiratory_system | 0.23702271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.69159939 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.38606142 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.15431961 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.99674527 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.54270334 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.42237996 |
| 7 | Xanthomatosis (HP:0000991) | 6.28281601 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.72421666 |
| 9 | Complement deficiency (HP:0004431) | 5.39982261 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.79088619 |
| 11 | Joint hemorrhage (HP:0005261) | 4.74701540 |
| 12 | Hyperammonemia (HP:0001987) | 4.68146041 |
| 13 | Epidermoid cyst (HP:0200040) | 4.53778514 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.51779674 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.51779674 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.51779674 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.49956585 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.41836831 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39295942 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.39205437 |
| 21 | Hyperglycinemia (HP:0002154) | 4.36030352 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.30663083 |
| 23 | Ketosis (HP:0001946) | 4.29426452 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.28570342 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.23249734 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.10052438 |
| 27 | Fat malabsorption (HP:0002630) | 4.01963859 |
| 28 | Abnormality of complement system (HP:0005339) | 3.94065027 |
| 29 | Hyperglycinuria (HP:0003108) | 3.89990833 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.87407456 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87407456 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.78113205 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.74703128 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.62517378 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.59287767 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37952726 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31942212 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.28048897 |
| 39 | Purpura (HP:0000979) | 3.23157788 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.15241595 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.13532367 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.10380084 |
| 43 | Spontaneous abortion (HP:0005268) | 3.09922275 |
| 44 | Steatorrhea (HP:0002570) | 3.07189032 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 3.05489082 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.04271141 |
| 47 | Ketoacidosis (HP:0001993) | 2.98089137 |
| 48 | Myocardial infarction (HP:0001658) | 2.97714493 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.94206973 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.85300882 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.80536291 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.80536291 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.80536291 |
| 54 | Skin nodule (HP:0200036) | 2.79839379 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.76880417 |
| 56 | Metabolic acidosis (HP:0001942) | 2.76177284 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.75870966 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.71259317 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71259317 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.67836174 |
| 61 | Lethargy (HP:0001254) | 2.64205956 |
| 62 | Increased serum ferritin (HP:0003281) | 2.61017067 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58734412 |
| 64 | Pulmonary embolism (HP:0002204) | 2.57361098 |
| 65 | Vascular calcification (HP:0004934) | 2.56999253 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.53107706 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53107706 |
| 68 | Spastic diplegia (HP:0001264) | 2.52171641 |
| 69 | Cerebral edema (HP:0002181) | 2.51682582 |
| 70 | Mitral stenosis (HP:0001718) | 2.49036404 |
| 71 | Gout (HP:0001997) | 2.46359807 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.43697399 |
| 73 | Neonatal onset (HP:0003623) | 2.42920291 |
| 74 | Irritability (HP:0000737) | 2.42164328 |
| 75 | Retinal atrophy (HP:0001105) | 2.41213731 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.40495941 |
| 77 | Glomerulonephritis (HP:0000099) | 2.40353759 |
| 78 | Fair hair (HP:0002286) | 2.38398071 |
| 79 | Cholelithiasis (HP:0001081) | 2.38048846 |
| 80 | Acanthocytosis (HP:0001927) | 2.37224847 |
| 81 | Amyloidosis (HP:0011034) | 2.36816109 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36637865 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.32261011 |
| 84 | Cholecystitis (HP:0001082) | 2.32261011 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.27847242 |
| 86 | Loss of speech (HP:0002371) | 2.24266447 |
| 87 | Gingival bleeding (HP:0000225) | 2.22779413 |
| 88 | Malnutrition (HP:0004395) | 2.20027366 |
| 89 | Gangrene (HP:0100758) | 2.19811859 |
| 90 | Disinhibition (HP:0000734) | 2.15593671 |
| 91 | Brushfield spots (HP:0001088) | 2.14589703 |
| 92 | Late onset (HP:0003584) | 2.14335027 |
| 93 | Esophageal varix (HP:0002040) | 2.12537585 |
| 94 | Pancreatitis (HP:0001733) | 2.12328151 |
| 95 | Enlarged kidneys (HP:0000105) | 2.11665822 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 2.11241835 |
| 97 | Menorrhagia (HP:0000132) | 2.11206613 |
| 98 | Thrombophlebitis (HP:0004418) | 2.10027993 |
| 99 | Neurofibrillary tangles (HP:0002185) | 2.09415786 |
| 100 | Vomiting (HP:0002013) | 2.08762155 |
| 101 | Opisthotonus (HP:0002179) | 2.04317873 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 1.98536751 |
| 103 | Optic neuritis (HP:0100653) | 1.98519430 |
| 104 | Retrobulbar optic neuritis (HP:0100654) | 1.98519430 |
| 105 | Generalized aminoaciduria (HP:0002909) | 1.98186490 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.96773367 |
| 107 | Elevated alkaline phosphatase (HP:0003155) | 1.95664558 |
| 108 | Orchitis (HP:0100796) | 1.95553192 |
| 109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95263427 |
| 110 | Neonatal hypoglycemia (HP:0001998) | 1.95005764 |
| 111 | Mutism (HP:0002300) | 1.94527368 |
| 112 | Poikilocytosis (HP:0004447) | 1.94323320 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.93856307 |
| 114 | Alkalosis (HP:0001948) | 1.91779268 |
| 115 | Rickets (HP:0002748) | 1.89466854 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.89286216 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89006605 |
| 118 | Mesangial abnormality (HP:0001966) | 1.88676838 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 1.87584658 |
| 120 | Status epilepticus (HP:0002133) | 1.86824545 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.86791472 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.86791472 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.86531358 |
| 124 | Pathologic fracture (HP:0002756) | 1.81737915 |
| 125 | Renal cortical cysts (HP:0000803) | 1.80057136 |
| 126 | Elevated hepatic transaminases (HP:0002910) | 1.79662384 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.79646253 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79247135 |
| 129 | Joint swelling (HP:0001386) | 1.79118188 |
| 130 | Hyperglycemia (HP:0003074) | 1.78761648 |
| 131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76476050 |
| 132 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75730190 |
| 133 | Epistaxis (HP:0000421) | 1.75243770 |
| 134 | Generalized hypopigmentation of hair (HP:0011358) | 1.74704957 |
| 135 | Axonal loss (HP:0003447) | 1.74054348 |
| 136 | Nephritis (HP:0000123) | 1.71205320 |
| 137 | Abnormality of vitamin metabolism (HP:0100508) | 1.70652891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24128875 |
| 2 | FGFR4 | 4.65161650 |
| 3 | ERN1 | 4.60057617 |
| 4 | SIK1 | 4.52443598 |
| 5 | GRK7 | 3.18813632 |
| 6 | ERBB4 | 3.04043506 |
| 7 | TAOK3 | 2.95290921 |
| 8 | INSRR | 2.93181380 |
| 9 | BLK | 2.90548430 |
| 10 | NME2 | 2.77722123 |
| 11 | ADRBK2 | 2.63929298 |
| 12 | MAP2K4 | 2.39850155 |
| 13 | ACVR1B | 2.23001812 |
| 14 | CAMKK2 | 2.20117885 |
| 15 | PKN2 | 2.19774574 |
| 16 | MST1R | 1.98174646 |
| 17 | IKBKB | 1.95224317 |
| 18 | MAPK11 | 1.91430226 |
| 19 | FLT3 | 1.83206199 |
| 20 | TRIB3 | 1.79968978 |
| 21 | MATK | 1.76555244 |
| 22 | PDK2 | 1.70549147 |
| 23 | TYK2 | 1.65683238 |
| 24 | PIK3CG | 1.65383527 |
| 25 | LATS1 | 1.58819396 |
| 26 | DDR2 | 1.57938895 |
| 27 | ABL2 | 1.53745297 |
| 28 | PTK6 | 1.51907183 |
| 29 | TXK | 1.50434242 |
| 30 | DAPK2 | 1.48469029 |
| 31 | PIM2 | 1.43939588 |
| 32 | FGFR2 | 1.36548537 |
| 33 | NEK9 | 1.33465791 |
| 34 | FRK | 1.28660185 |
| 35 | JAK2 | 1.24143174 |
| 36 | MAP4K1 | 1.24021645 |
| 37 | KDR | 1.21852178 |
| 38 | MAP3K7 | 1.19354967 |
| 39 | CHUK | 1.17294981 |
| 40 | PINK1 | 1.15952863 |
| 41 | GRK6 | 1.14132039 |
| 42 | FGR | 1.14032245 |
| 43 | TBK1 | 1.13224520 |
| 44 | TNK2 | 1.12263263 |
| 45 | PRKAA2 | 1.12052022 |
| 46 | MAP2K3 | 1.05929309 |
| 47 | ERBB2 | 1.05877562 |
| 48 | TAOK1 | 1.02731773 |
| 49 | JAK1 | 1.00804901 |
| 50 | MAP3K14 | 1.00727900 |
| 51 | IRAK4 | 1.00528699 |
| 52 | MAPK4 | 1.00402576 |
| 53 | ZAP70 | 0.98357437 |
| 54 | MAP3K10 | 0.94358145 |
| 55 | CDC42BPA | 0.94196995 |
| 56 | LYN | 0.92562223 |
| 57 | PRKCZ | 0.92279710 |
| 58 | EPHB1 | 0.89803162 |
| 59 | MOS | 0.89212895 |
| 60 | SYK | 0.88213991 |
| 61 | KIT | 0.87942263 |
| 62 | MAPK15 | 0.87897117 |
| 63 | MAPK12 | 0.86200248 |
| 64 | EPHA3 | 0.84717195 |
| 65 | CDK6 | 0.81379223 |
| 66 | MAP3K3 | 0.80388645 |
| 67 | STK38L | 0.80165901 |
| 68 | MAP3K11 | 0.79745734 |
| 69 | CAMK2G | 0.79075160 |
| 70 | MET | 0.77946192 |
| 71 | DYRK1B | 0.77537830 |
| 72 | CAMKK1 | 0.77255206 |
| 73 | JAK3 | 0.76893655 |
| 74 | PRKACG | 0.76524187 |
| 75 | MAP2K6 | 0.74047348 |
| 76 | CSK | 0.72051898 |
| 77 | TIE1 | 0.71342514 |
| 78 | GSK3A | 0.66188037 |
| 79 | LCK | 0.65923016 |
| 80 | SGK3 | 0.64476449 |
| 81 | PRKAA1 | 0.62713670 |
| 82 | FES | 0.60824945 |
| 83 | MAPK7 | 0.60678181 |
| 84 | CAMK1D | 0.60639763 |
| 85 | IKBKE | 0.59630343 |
| 86 | PRPF4B | 0.59217507 |
| 87 | EPHA4 | 0.58552930 |
| 88 | FGFR3 | 0.58439679 |
| 89 | IRAK3 | 0.57902129 |
| 90 | RIPK1 | 0.56953357 |
| 91 | TAOK2 | 0.56527248 |
| 92 | NTRK3 | 0.55117477 |
| 93 | PDPK1 | 0.54559653 |
| 94 | PTK2 | 0.54326956 |
| 95 | TGFBR2 | 0.54270437 |
| 96 | CSF1R | 0.51699121 |
| 97 | ARAF | 0.51606727 |
| 98 | MAP3K13 | 0.51262104 |
| 99 | CSNK1G1 | 0.51163043 |
| 100 | PRKCQ | 0.50867125 |
| 101 | TGFBR1 | 0.50842356 |
| 102 | MARK3 | 0.49696587 |
| 103 | PRKACA | 0.49111785 |
| 104 | PRKG1 | 0.48603068 |
| 105 | PKN1 | 0.48175204 |
| 106 | MAP3K5 | 0.47411324 |
| 107 | WNK3 | 0.46385108 |
| 108 | SGK2 | 0.45322985 |
| 109 | FER | 0.45241015 |
| 110 | RIPK4 | 0.45065726 |
| 111 | IGF1R | 0.43760503 |
| 112 | MAP2K1 | 0.43507539 |
| 113 | PRKCG | 0.41780144 |
| 114 | RET | 0.41746768 |
| 115 | BMPR2 | 0.41510486 |
| 116 | MAP4K2 | 0.40971135 |
| 117 | GRK1 | 0.40104965 |
| 118 | CDK4 | 0.39961451 |
| 119 | ICK | 0.38613790 |
| 120 | MAP3K6 | 0.38091623 |
| 121 | RPS6KA6 | 0.37496541 |
| 122 | CAMK4 | 0.36035945 |
| 123 | EGFR | 0.35632906 |
| 124 | MTOR | 0.34179758 |
| 125 | RPS6KL1 | 0.33676722 |
| 126 | RPS6KC1 | 0.33676722 |
| 127 | CSNK1G2 | 0.33586512 |
| 128 | PDK1 | 0.32825440 |
| 129 | HCK | 0.31638445 |
| 130 | RPS6KA2 | 0.30836905 |
| 131 | IRAK1 | 0.30372152 |
| 132 | SGK494 | 0.30305174 |
| 133 | SGK223 | 0.30305174 |
| 134 | CSNK1G3 | 0.30175271 |
| 135 | MAP3K1 | 0.28723447 |
| 136 | LATS2 | 0.27964015 |
| 137 | IRAK2 | 0.27550771 |
| 138 | PRKCA | 0.26135530 |
| 139 | PIK3CA | 0.24624122 |
| 140 | PBK | 0.23214158 |
| 141 | ABL1 | 0.21609889 |
| 142 | CSNK1A1L | 0.20678420 |
| 143 | PDK3 | 0.19785876 |
| 144 | PDK4 | 0.19785876 |
| 145 | PAK3 | 0.19630729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55509164 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.65088694 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56087499 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32495288 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.25306432 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75933627 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71171155 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63183060 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58603699 |
| 10 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46743989 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43630032 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35479385 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24111172 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14231938 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09011527 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06661608 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95072376 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92874058 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92415898 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92198644 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88530234 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85420683 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82760824 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.82583637 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77905305 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74454070 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73838547 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68702129 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66724985 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64674417 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64090953 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58793744 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57521070 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57254668 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52706315 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47647050 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.47160957 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46259363 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35485733 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34257376 |
| 41 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28256069 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26842961 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26121782 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25044626 |
| 45 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19410527 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.16982576 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14447591 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13320146 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.10090265 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07516775 |
| 51 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.06014154 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99958753 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99021778 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.98588783 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98494722 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98121859 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95047242 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89991449 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87993332 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87093331 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81301783 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.80015566 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74195001 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69440023 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65961155 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65872261 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64772343 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55551215 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49495057 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48482097 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47696262 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.47660524 |
| 73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45543862 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41198333 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.38596258 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.34397440 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29824213 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26203417 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.25630155 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25222523 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24979179 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24165947 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.24076763 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23496901 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23098051 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.23038732 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22846209 |
| 88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22811141 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21559048 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20960113 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.20887252 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20711139 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.17319292 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.17288202 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.17018315 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16282895 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15222651 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.12175010 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11073156 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.09908999 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.07365353 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.03900930 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02638956 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2533621 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2413538 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2379183 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.2284163 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2208074 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2055584 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2043271 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1950781 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | -0.1836469 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1774259 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1584484 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1550193 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1506394 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1496842 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1353967 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1313266 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0992459 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0879481 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0812461 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0684653 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0418198 |

